文献速递免疫规划传染病防控与疫情报告

利用间歇性强化监测评估澳大利亚昆士兰州水痘和带状疱疹疫苗接种的影响

Assessing the impact of chickenpox and shingles vaccination using intermittent enhanced surveillance in Queensland, Australia.
PubMed 文献 · Vaccine · 2023-11-18

本研究利用2010年1月至2021年12月昆士兰州水痘-带状疱疹病毒(VZV)通报病例,结合临床医生随访的间歇性强化监测,分析疫苗接种引入后VZV流行病学变化。结果显示VZV总通报率每年估计增加5.7%(95%CI 4.9-6.4),但水痘在18-23月龄较<12月龄和12-17月龄分别低57%和36%,70-79岁带状疱疹通报率在2017-2021年较疫苗引入前下降12-22%。

要点

  • VZV总通报率2010-2021年每年估计增加5.7%(95%CI 4.9-6.4)。
  • 水痘通报率在18-23月龄较<12月龄和12-17月龄分别低57%和36%。
  • 70-79岁带状疱疹通报率2017-2021年较疫苗引入前下降12-22%。

核心结论

  • 昆士兰州VZV通报率随时间增加。
  • 国家免疫规划资助的水痘和带状疱疹疫苗在符合接种年龄的队列中可见通报率下降。
  • 引入儿童第二剂水痘疫苗和更有效的重组带状疱疹疫苗可能进一步改善疫苗接种规划的影响。

研究设计与样本

  • 病例系列研究,使用2010年1月至2021年12月昆士兰州VZV感染通报病例。
  • VZV通报多为病理实验室报告的临床未指定病例。
  • 通过临床医生随访进行间歇性强化监测以确定水痘和带状疱疹临床表现,并按年龄组、时间段和疫苗符合队列分析。

主要发现

  • 共收到87,759例VZV通报,其中70%(n=61,298)为未指定,23%(n=19,927)为带状疱疹,7%(n=6,534)为水痘。
  • 研究期间经年龄和性别调整的总通报百分比变化估计为每年增加5.7%(95%CI 4.9-6.4)。
  • 水痘通报在18月龄(符合水痘疫苗条件)急剧下降,18-23月龄的通报率较<12月龄低57%,较12-17月龄低36%。
  • 假设所有60岁及以上病例均为带状疱疹,2016年疫苗引入后,70-79岁(符合带状疱疹疫苗条件)的带状疱疹通报率在2017-2021年间下降12-22%。

关键数值与推荐

  • 水痘通报率:18-23月龄较<12月龄低57%,较12-17月龄低36%。
  • 带状疱疹通报率:70-79岁在2017-2021年较疫苗引入前下降12-22%。
  • 总VZV通报率:经年龄和性别调整后每年增加5.7%(95%CI 4.9-6.4)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Chickenpox and shingles are vaccine preventable diseases caused by varicella-zoster virus (VZV). Chickenpox is more common in children before adolescence and shingles among ≥50 years of age. With this study we aimed to determine changes in VZV epidemiology following chickenpox and shingles vaccine introduction in Queensland. METHODS: This case series study used notified cases of VZV infection in Queensland from January 2010 to December 2021. In Queensland, VZV notifications are received as mostly clinically unspecified cases from pathology laboratories. Intermittent enhanced surveillance was conducted using clinician follow up to determine chickenpox and shingles clinical presentation, and we then analysed these by age-group, time period, and within vaccine eligible cohorts. RESULTS: Of the 87,759 VZV notifications received, 70 % (n = 61,298) were notified as unspecified, followed by 23 % shingles (n = 19,927), and 7 % chickenpox (n = 6,534). Over the study period, the percent change in total notifications adjusted by age and sex was estimated to be an increase of 5.7 % (95 % CI 4.9-6.4) each year. The chickenpox notifications fell sharply at 18 months of age (eligible for chickenpox vaccine) with the rate being 57 % and 36 % lower among those aged 18-23 months compared to <12 and 12-17 months of age, respectively. Assuming all cases aged 60 years and older were shingles, notification rates of shingles decreased by 12-22 % among 70-79 years old (eligible for shingles vaccination) over the years 2017-2021 after vaccine introduction in 2016. CONCLUSION: The VZV notification rate has increased over time in Queensland. Impact of chickenpox and shingles vaccines funded under National Immunisation Program is seen with a decline in notification rates among age-specific cohorts eligible to receive the vaccines under the program. Introduction of a second childhood dose chickenpox vaccine and more effective recombinant shingles vaccine may further improve the impact of the vaccination program.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Shrestha AC, Field E, Rajmokan M, et al. Assessing the impact of chickenpox and shingles vaccination using intermittent enhanced surveillance in Queensland, Australia. Vaccine. 2023. PMID: 37980260. doi:10.1016/j.vaccine.2023.11.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。